Appointment booking for Dr. Asia Mubashir, MD is currently not available.Dr. Asia Mubashir, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Asia Mubashir, MD (she/her) is a Rheumatologist in Baltimore, MD with over 17 years of experience. What is your opinion of Dr. Asia Mubashir, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 17 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Asia Mubashir, MD has received over $2,827 which includes payments from the following companies:
$501.06 from Celgene Corporation
$327.17 from Amgen Inc.
$300.76 from E.R. Squibb & Sons, L.L.C.
$191.20 from AbbVie, Inc.
$156.59 from Pfizer Inc.
$156.58 from Novartis Pharmaceuticals Corporation
$152.00 from Genentech, Inc.
$132.08 from Genentech USA, Inc.
$124.00 from Janssen Scientific Affairs, LLC
$112.49 from Merck Sharp & Dohme Corporation
$109.50 from UCB, Inc.
$98.61 from LILLY USA, LLC
$95.63 from Janssen Biotech, Inc.
$72.85 from Radius Health, Inc.
$69.51 from GlaxoSmithKline, LLC.
$47.73 from GENZYME CORPORATION
$44.05 from Horizon Pharma plc
$38.08 from West-Ward Pharmaceuticals
$21.27 from Flexion Therapeutics, Inc.
$18.90 from Crealta Pharmaceuticals LLC
Payments received by Dr. Asia Mubashir, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!